Literature DB >> 19332634

Remission in rheumatoid arthritis: physician and patient perspectives.

Frederick Wolfe1, Maarten Boers, David Felson, Kaleb Michaud, George A Wells.   

Abstract

OBJECTIVE: To examine the prevalence of remission in rheumatoid arthritis (RA) as determined by physicians and patients independently, and to determine the degree of agreement among methods, the strength of predictor variables of remission, and the length of remission.
METHODS: Eight hundred patients with RA completed a remission questionnaire on the day of their rheumatologist visit and their rheumatologists completed a separate questionnaire the same day. The question(s) were: "Given all your experience with disease activity in RA, are you [is your patient] currently in remission?". Patients also completed 0-10 visual analog scales for RA activity, pain, and functional limitation.
RESULTS: The percentage of patients in remission by physician and patient assessment was 34.8% [95% confidence interval (CI) 31.4-38.2] and 30.9% (95% CI 27.7-34.20), respectively. The percentage of patients classified concordantly (full agreement) was 78.6%, and the associated kappa statistic was 0.54 (95% CI 0.45-0.58). The median duration of remission was 2.0 years. The median RA activity, pain, and functional scores were 1.0, 1.5, and 1.25 for patient-determined remission and 1.5, 1.5, and 1.5 for physician-determined remission.
CONCLUSION: Physician and patient estimates of remission in RA are similar (34.8% to 30.9%), and agreement was 78.6% (kappa 0.53). Based on previous data and the observed presence of disease activity, this definition of remission appears to be a measure of minimal disease activity rather than true remission. The problem of remission rates will not be solved until a consensus definition that has relevance in research and the clinic is developed.

Entities:  

Mesh:

Year:  2009        PMID: 19332634     DOI: 10.3899/jrheum.080947

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

Review 1.  Remission in rheumatoid arthritis.

Authors:  Rania M Shammas; Veena K Ranganath; Harold E Paulus
Journal:  Curr Rheumatol Rep       Date:  2010-10       Impact factor: 4.592

2.  Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study.

Authors:  Yvonne C Lee; Jing Cui; Bing Lu; Michelle L Frits; Christine K Iannaccone; Nancy A Shadick; Michael E Weinblatt; Daniel H Solomon
Journal:  Arthritis Res Ther       Date:  2011-06-08       Impact factor: 5.156

3.  Patient-physician discrepancy in the perception of immune-mediated inflammatory diseases: rheumatoid arthritis, psoriatic arthritis and psoriasis. A qualitative systematic review of the literature.

Authors:  José Antonio Sacristán; Tatiana Dilla; Silvia Díaz-Cerezo; Clara Gabás-Rivera; Susana Aceituno; Luis Lizán
Journal:  PLoS One       Date:  2020-06-17       Impact factor: 3.240

4.  Pain, sleep and emotional well-being explain the lack of agreement between physician- and patient-perceived remission in early rheumatoid arthritis.

Authors:  Samina A Turk; Linda A Rasch; Dirkjan van Schaardenburg; Willem F Lems; Marjolein Sanberg; Lilian H D van Tuyl; Marieke M Ter Wee
Journal:  BMC Rheumatol       Date:  2018-06-26

5.  Factors predicting pain and early discontinuation of tumour necrosis factor-α-inhibitors in people with rheumatoid arthritis: results from the British society for rheumatology biologics register.

Authors:  Daniel F McWilliams; David A Walsh
Journal:  BMC Musculoskelet Disord       Date:  2016-08-12       Impact factor: 2.362

6.  Induction maintenance with tumour necrosis factor-inhibitor combination therapy with discontinuation versus methotrexate monotherapy in early rheumatoid arthritis: a systematic review and meta-analysis of efficacy in randomised controlled trials.

Authors:  Sharzad Emamikia; Elizabeth V Arkema; Noémi Györi; Jacqueline Detert; Katerina Chatzidionysiou; Maxime Dougados; Gerd Rüdiger Burmester; Ronald van Vollenhoven
Journal:  RMD Open       Date:  2016-09-06

7.  Factors Contributing to Discordance between the 2011 ACR/EULAR Criteria and Physician Clinical Judgment for the Identification of Remission in Patients with Rheumatoid Arthritis.

Authors:  Yoon Kyoung Sung; Soo Kyung Cho; Dam Kim; Bo Young Yoon; Chan Bum Choi; Hoon Suk Cha; Jung Yoon Choe; Won Tae Chung; Seung Jae Hong; Jae Bum Jun; Young Mo Kang; Jinseok Kim; Tae Hwan Kim; Tae Jong Kim; Eunmi Koh; Choong Ki Lee; Jisoo Lee; Shin Seok Lee; Sung Won Lee; Hye Soon Lee; Yeon Ah Lee; Sung Hoon Park; Dae Hyun Yoo; Wan Hee Yoo; Sang Cheol Bae
Journal:  J Korean Med Sci       Date:  2016-12       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.